ANXA1 and systemic lupus erythematosus: Consequently, treatment with the ANXA1-mimetic peptide Ac2-26 attenuated macrophage-driven fibrosis, reduced renal lipid accumulation, and ameliorated kidney injury in lupus-prone mice.